B. Naisbett-Groet

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.

R. Moots, B. Naisbett-Groet, 2012, Rheumatology.

FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial

C. Edwards, A. Ostor, P. Kiely, 2016 .

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial

P. Kiely, C. Edwards, B. Naisbett-Groet, 2018, Rheumatology.

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study

J. Isaacs, E. Choy, N. McKay, 2019, Rheumatology advances in practice.

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK

M. Samnaliev, S. Langham, J. Langham, 2023, Rheumatology and Therapy.

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

M. Samnaliev, S. Langham, J. Langham, 2023, Rheumatology and Therapy.